| 000 | 01752cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031031.0 | ||
| 008 | 140902s2013 ua f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.19.M.Sc.2013.Es.E | ||
| 100 | 0 | _aEssraa Adel Aly Aly Hegazy | |
| 245 | 1 | 0 |
_aEvaluation of immune response to hepatitis B vaccine in Egyptian children / _cEssraa Adel Aly Aly Hegazy ; Supervised Hala Mohamed Safouh , Ashraf Elsayed Abdelhamid |
| 246 | 1 | 5 | _aتقييم الاستجابة المناعية للقاح التهاب الكبد (ب) فى الاطفال المصريين |
| 260 |
_aCairo : _bEssraa Adel Aly Aly Hegazy , _c2013 |
||
| 300 |
_a173 P. ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology | ||
| 520 | _aThe participants in this study were 182 children. 110 males and 72 females categorized into eight age groups from 2 - 10 years of age. Serum samples from each participant were tested for the quantitative determination of anti - HBs antibody using enzyme linked immunosorbent assay (ELISA) as well as qualitative ELISA testing for HBsAg and HBcAb. The study showed that the efficacy of hepatitis B vaccine, as evidenced by presence of protective levels of HbsAb, is 88.5% | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aEgyptian children | |
| 653 | 4 | _aEvaluation of immune response | |
| 653 | 4 | _aHepatitis B | |
| 700 | 0 |
_aAshraf Elsayed Abdelhamid , _eSupervisor |
|
| 700 | 0 |
_aHala Mohamed Safouh , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c47086 _d47086 |
||